9 Devices
CooperVision Inc. - Applicant Profile
CooperVision Inc.
CooperVision Inc. is associated with 9 medical devices registered under the Hong Kong Medical Device Administrative Control System (MDACS). Explore bilingual product names, risk classes, authorised representatives, and life-cycle milestones.
1 Risk Classes
Since 2020
Latest 2024
Applicant Overview
Bilingual manufacturer details sourced from Hong Kong MDACS.
Applicant (EN)
CooperVision Inc.
Country
United States
็พๅฝ
Applicant (ZH)
CooperVision Inc.
Address
711 North Road, Scottsville, New York, 14546, USA
711 North Road, ๆฏ็ง่จ็ปดๅฐ, ็บฝ็บฆ, 14546, ็พๅฝ
Recent MDACS Registrations
Latest 15 devices linked to this applicant.
| Device | Risk Class | Authorised Rep | Registered |
|---|---|---|---|
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Oct 15, 2024 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Jul 26, 2023 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Jan 17, 2022 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Jan 17, 2022 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Jan 17, 2022 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Jan 17, 2022 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Jan 17, 2022 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Feb 03, 2021 |
| Contact Lenses, Vision Corrective ้ๅฝข็ผ้,่งๅ็ซๆญฃ | II | Coopervision Hong Kong Limited ้
ทๆๅ
ๅญฆ(้ฆๆธฏ)ๆ้ๅ
ฌๅธ | Apr 17, 2020 |
Risk Class Breakdown
II9
Timeline
First Registration
Apr 17, 2020
Most Recent
Oct 15, 2024

